Press "Enter" to skip to content

New patent for APGDI drug MYRBETRIQ GRANULES

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MYRBETRIQ+GRANULES
Annual Drug Patent Expirations for MYRBETRIQ+GRANULES

Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

Drug patent litigation for MYRBETRIQ GRANULES.

This drug has fifty-two patent family members in twenty-two countries.

The generic ingredient in MYRBETRIQ GRANULES is mirabegron. One supplier is listed for this compound. Additional details are available on the mirabegron profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions